Navigation Links
DIA And FDA To Host Two Important Critical Path Workshops
Date:7/25/2008

The Drug Information Association (DIA) and the Food and Drug Administration (FDA) will host the Critical Path Initiative (CPI) on the Move: Complexities and Challenges (September 15 -16; Bethesda, MD) and the Critical Path Transporter Workshop (October 2-3; North Bethesda, MD).

Horsham, PA (PRWEB) July 25, 2005-- The http://www.diahome.org/ [Drug Information Association (DIA)] and the Food and Drug Administration (FDA) will host the http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17181&eventType=Meeting [Critical Path Initiative (CPI) on the Move: Complexities and Challenges] (September 15 -16; Bethesda, MD) and the http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17183&eventType=Meeting [Critical Path Transporter Workshop] (October 2-3; North Bethesda, MD).

"The FDA Critical Path Initiative is a key FDA science-based effort to modernize the science and tools used in the development, evaluation, manufacture, and use of all FDA-regulated products, explains Program Co-chair Rachel E. Behrman, MD, MPH, Director, Office of Critical Path Programs, OC, FDA. "This workshop will explore what has been accomplished, current projects and their status, and future opportunities."

The http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17181&eventType=Meeting [Critical Path Initiative (CPI) on the Move: Complexities and Challenges] will feature speakers/panelists such as Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA; Mark B. McClellan, MD, PhD, Chair, Reagan-Udall Foundation and Director, Engelberg Center for Health Care Reform Brookings; and Raymond Woosley, MD, PhD, President and CEO, Critical Path Institute.

The http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=17183&eventType=Meeting [Critical Path Transporter Workshop] will be held in collaboration with PhRMA, the American Association of Pharmaceutical Scientists, and International Society for the Study of Xenobiotics.

"Leading scientists from academia, the FDA, and industry will present and lead discussion on the current status of the rapidly emerging field of drug transporters, the clinical relevance of drug uptake and efflux transporters, and the application of in vitro and in vivo tools to drug discovery and development," notes Program Committee Member Shiew-Mei Huang, PhD, FCP, Deputy Director, Office of Clinical Pharmacology, CDER, FDA.

Featured sessions will include:

  • Focus on key transporters
  • Current and future technical challenges
  • Drug development and FDA examples

In March 2004, FDA first announced the Critical Path Initiative, which was designed to identify additional mechanisms through applied scientific studies to develop better methods and new technologies that may improve the product development process. Since that time, a number of efforts have launched to leverage collaborations to modernize development of new genomic, imaging, statistical, methodological, analytical, and informatics tools, with the ultimate goal of reducing the uncertainty about product performance throughout the medical product life cycle.

About the http://www.diahome.org/ [Drug Information Association (DIA)]
The Drug Information Association serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

###

Read the full story at http://www.prweb.com/releases/DIA/FDA/prweb1142424.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
2. New class of RNA molecules may be important in human cancer
3. UVA researchers find important clue to immune infertility
4. Catholic Charities USA Calls on Congress and the President to Protect the Health of Children; Urges President Not to Veto Vitally Important Bill
5. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
6. Daytime, Nighttime Blood Pressure Both Important
7. Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF
8. Video: Holiday Safety Is Important
9. Quality of life: most important predictor of survival for advanced NSCLC patients
10. Research highlights important indicators of early-stage ovarian cancer
11. The most important candidate genes for pancreatic stone formation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... It’s that time of year when most people have forgotten all about their New ... (IAAM), Hall of Fame athlete and Garrison Forest School athletic director since 2005, knows ... of her first decisions when her IAAM two-year presidency began last July was to ...
(Date:2/9/2016)... Albuquerque, NM (PRWEB) , ... February 09, 2016 , ... ... proceeds from its Heart Rate Variability scans throughout the month to the American Heart ... to spot the first signs of heart disease and Health Quest’s INSiGHT Pulse Wave ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... Snowfall4pod Digital, creators of the gContentManager & Distribution Network, today announced the ... and print-on-demand network. , AVALANCHE allows enterprise customers to license and create ...
(Date:2/9/2016)... ... February 10, 2016 , ... The Journal of Pain Research ... playing field .” , As corresponding author Dr John F. Peppin says “Terminology matters, ... diagnose our chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer pain’ are ...
(Date:2/9/2016)... ... 2016 , ... METTLER TOLEDO has published a new guide ... understanding of the techniques they use so they can more easily spot potential ... and rework to create a leaner overall lab experience. , The new ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  Landauer, Inc. (NYSE: LDR ), a ... monitoring, outsourced medical physics services and high quality medical ... 2016 first quarter ended December 31, 2015. ... First Quarter Highlights , Revenue of $36.5 million ... 2015 , Domestic Radiation Measurement services revenues increased 2.8% ...
(Date:2/9/2016)... , February 9, 2016 ... gab heute den Abschluss eines Kooperationsvertrags mit ... umfassender Lösungen in den Bereichen Next-Generation-Sequencing (NGS), ... QGEN ; Frankfurt Prime Standard: QIA) gab ... Genomics für die Entwicklung und Förderung umfassender ...
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
Breaking Medicine Technology: